The Anti-Inflammatory Agent Bindarit Attenuates the Impairment of Neural Development through Suppression of Microglial Activation in a Neonatal Hydrocephalus Mouse Model

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 5.
Figure 5.

Impaired development of the cortical plate in the prh mutant and ameliorative effect by bindarit in Layers II–IV. A, Cortical layer-specific markers SATB2 (II–IV), CTIP2 (V), and TBR1 (VI) are used to stain layer-specific cortical neurons in veh-/bin- WT and prh (scale bars: 100 μm). (B, top row) The thickness of cortical Layer II through IV is significantly reduced in veh-prh, and this defect is improved in bin-prh cortex (††††p < 0.0001 vs veh-WT, ‡p = 0.0264, ‡‡‡‡p < 0.0001 vs bin-WT, *p = 0.0110 vs veh-prh; two-way ANOVA followed by Tukey's test, n = 9–10 in each group; left top). B, bottom row, The cell density of SATB2+ neurons in cortical Layers II–IV are not significantly changed between groups (left bottom). CTIP2+ cortical Layer V thickness is reduced in prh (§§§p = 0.0005, prh vs WT) and not recovered by bindarit (p = 0.9869, bin-prh vs veh-prh, two-way ANOVA followed by Tukey's test, n = 9–10 in each group; middle top). TBR1+ Layer VI thickness (right top), as well as the cell density of CIPT2 (middle bottom)/TBR1 (right bottom) positive Layer V/VI neurons are not significantly altered in prh mutants.

  1. The Journal of Neuroscience vol. 42 no. 9 1820-1844
Responses to This Article
Be the first to respond to this article
Advertisement